Related Experiment Video
Updated: Aug 25, 2026
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
[Gene therapy for the treatment of patients with brain gliomas]
Jerzy Słowiński1, Ryszard Mrówka
1Katedra i Oddział Kliniczny Neurochirurgii i Neurotraumatologii, Slaska Akademia Medyczna, al. Leginów 10, 41-902 Bytom. slowian@mp.pl
Abstract:
The prognosis of patients with brain gliomas remains poor despite the use of advanced surgical techniques, radio- and chemotherapy. In this respect, gene engineering techniques altering the glioma genome in order to regulate the function of key genes involved in cancerogenesis seem to be promising. The premise for applying a gene therapy in patients with brain gliomas is described, together with basic strategies and results of hitherto performed experimental and clinical studies, mostly with the use of virus vectors. The rapid progress in molecular techniques may enable to overcome methodological problems related to the introduction of the therapeutic gene into the target cell, and thus to improve so far unsatisfactory results of glioma gene therapy. The important role of a neurosurgeon in the process of precise gene vector application to the tumour area should not be underestimated.
Insights
Gene therapy offers a promising approach to improve outcomes for brain glioma patients. Advances in molecular techniques and precise gene vector delivery by neurosurgeons are key to overcoming current treatment limitations.
Area of Science:
- Neuro-oncology
- Molecular biology
- Gene therapy
Background:
- Brain gliomas have a poor prognosis despite conventional treatments.
- Gene engineering presents a promising avenue for glioma treatment by targeting cancer-causing genes.
Purpose of the Study:
- To describe the rationale for gene therapy in brain gliomas.
- To review current gene therapy strategies and study results.
- To highlight the role of neurosurgeons in gene vector delivery.
Main Methods:
- Review of experimental and clinical studies on glioma gene therapy.
- Focus on virus vector-mediated gene delivery.
- Discussion of molecular techniques for gene introduction.
Main Results:
- Gene therapy holds potential for improving glioma treatment outcomes.
- Virus vectors are commonly used for gene delivery in current studies.
- Methodological challenges in gene delivery are being addressed by molecular advancements.
Conclusions:
- Gene therapy is a promising strategy for brain gliomas.
- Progress in molecular techniques may enhance gene therapy efficacy.
- Precise gene vector application by neurosurgeons is crucial for successful treatment.
